Overview

Efficacy of Esomeprazole in Patients With Frequent Heartburn

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This study will investigate the efficacy of esomeprazole 20 mg once a day in the treatment of frequent heartburn
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Esomeprazole